Hot Mail: Temperature Exposure during Mail Return of an Immunochemical Fecal Occult Blood Test

被引:1
|
作者
Laven-Law, Geraldine [1 ,2 ,4 ]
Bastin, Dawn [1 ,2 ]
Fraser, Robert J. L. [2 ,3 ]
Cock, Charles [2 ,3 ]
Young, Graeme P. [1 ,2 ]
Winter, Jean M. [1 ,2 ]
Symonds, Erin L. [1 ,2 ,3 ]
机构
[1] Flinders Hlth & Med Res Inst, Canc Res, Bedford Pk, SA, Australia
[2] Flinders Univ S Australia, Coll Med & Publ Hlth, Bedford Pk, SA, Australia
[3] Flinders Med Ctr, Dept Gastroenterol & Hepatol, Adelaide, SA, Australia
[4] Flinders Hlth & Med Res Inst, Flinders Ctr Innovat Canc, Flinders Med Ctr, Canc Res, Level 3,Flinders Dr, Bedford Pk, SA 5042, Australia
关键词
HEMOGLOBIN; PERFORMANCE; BUFFER; PROGRAM; TIME; FIT;
D O I
10.1093/clinchem/hvad052
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Fecal immunochemical tests (FITs) are widely used for colorectal cancer (CRC) screening; however, high ambient temperatures were found to reduce test accuracy. More recently, proprietary globin stabilizers were added to FIT sample buffers to prevent temperature-associated hemoglobin (Hb) degradation, but their effectiveness remains uncertain. We aimed to determine the impact of high temperature (>30 degrees C) on OC-Sensor FIT Hb concentration with current FITs, characterize FIT temperatures during mail transit, and determine impact of ambient temperature on FIT Hb concentration using data from a CRC screening program. Methods FITs were analyzed for Hb concentration after in vitro incubation at different temperatures. Data loggers packaged alongside FITs measured temperatures during mail transit. Separately, screening program participants completed and mailed FITs to the laboratory for Hb analysis. Regression analyses compared the impact of environmental variables on FIT temperatures and separately on FIT sample Hb concentration. Results In vitro incubation at 30 to 35 degrees C reduced FIT Hb concentration after >4 days. During mail transit, maximum FIT temperature averaged 6.4 degrees C above maximum ambient temperature, but exposure to temperature above 30 degrees C was for less than 24 hours. Screening program data showed no association between FIT Hb concentration and maximum ambient temperatures. Conclusions Although FIT samples are exposed to elevated temperatures during mail transit, this is brief and does not significantly reduce FIT Hb concentration. These data support continuation of CRC screening during warm weather with modern FITs with a stabilizing agent when mail delivery is <= 4 days.
引用
收藏
页码:615 / 626
页数:12
相关论文
共 50 条
  • [31] Randomized Trial Comparing the Test Characteristics of Immunochemical Fecal Occult Blood Test At Different Cut-Off Levels to Guaiac-Based Fecal Occult Blood Test
    Hol, Lieke
    Wilschut, Janneke
    van Ballegooijen, Marjolein
    van Vuuren, Anneke
    van der Valk, Hans
    Reijerink-Verheij, Jacqueline C.
    van der Togt-van Leeuwen, Alexandra C.
    Kuipers, Ernst J.
    Habbema, J. D.
    van Leerdam, Monique
    GASTROENTEROLOGY, 2009, 136 (05) : A622 - A622
  • [32] Fecal immunochemical tests—what are the advantages compared to the guaiac-based fecal occult blood test?
    Brenner H.
    Gies A.
    best practice onkologie, 2019, 14 (5) : 190 - 194
  • [33] Utility of fecal immunochemical test vs guaiac fecal occult blood test for assessment of gastrointestinal bleed in hospitalized patients
    Sokoro, AbdulRazaq
    Shafer, Leigh Anne
    Darr, Mitchell
    Singh, Harminder
    CLINICA CHIMICA ACTA, 2020, 500 : 202 - 207
  • [34] Temporal Trends in Using Fecal Immunochemical Test (FIT) vs Fecal Occult Blood Test (FOBT) Under Medicare
    El Zoghbi, Maysaa
    Kou, Tzuyung D.
    Cooper, Gregory S.
    GASTROENTEROLOGY, 2015, 148 (04) : S757 - S757
  • [35] RAPID IMMUNOCHEMICAL DETECTION OF FECAL OCCULT BLOOD BY USE OF A LATEX-AGGLUTINATION TEST
    VAANANEN, P
    TENHUNEN, R
    CLINICAL CHEMISTRY, 1988, 34 (09) : 1763 - 1766
  • [36] Four Rounds of Two-Sample Fecal Immunochemical Occult Blood Test Screening
    Schreuders, Eline H.
    Grobbee, Esmee J.
    Kapidzic, Atija
    van Roon, Aafke H.
    van Vuuren, Anneke
    Lansdorp-Vogelaar, Iris
    Izelaar, Kirsten
    Bruno, Marco J.
    Kuipers, Ernst J.
    Spaander, Manon
    GASTROENTEROLOGY, 2016, 150 (04) : S751 - S751
  • [37] Immunochemical fecal occult blood test for detection of rectosigmoid cancer in asymptomatic adults.
    Kim, YH
    Kim, J
    Son, HJ
    Rhee, PL
    Koh, KC
    Paik, SW
    Rhee, JC
    Choi, KW
    GASTROENTEROLOGY, 1998, 114 (04) : A625 - A625
  • [38] Performance of the immunochemical fecal occult blood test in predicting lesions in the lower gastrointestinal tract
    Chiang, Tsung-Hsien
    Lee, Yi-Chia
    Tu, Chia-Hung
    Chiu, Han-Mo
    Wu, Ming-Shiang
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2011, 183 (13) : 1474 - 1481
  • [39] A further evaluation of the new immunochemical fecal occult blood test FlexSure® OBT.
    St John, DJB
    Sinatra, MA
    Young, GP
    Tilkeridis, J
    Alexeyeff, MA
    GASTROENTEROLOGY, 1998, 114 (04) : A684 - A684
  • [40] Immunochemical Fecal Occult Blood Test Screening Results prior to Colorectal Cancer Diagnosis
    Petersen, J. M.
    Dalal, S.
    Jhala, D.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2022, 158 (SUPP 1) : S43 - S43